You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,973,934


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,973,934 protect, and when does it expire?

Patent 10,973,934 protects ELUCIREM and is included in one NDA.

This patent has nineteen patent family members in thirteen countries.

Summary for Patent: 10,973,934
Title:Gadolinium bearing PCTA-based contrast agents
Abstract:The present invention relates to the RRR/SSS pair of enantiomers of the of Gd(PCTA-tris-glutaric acid), the single enantiomers of the pair, the pharmaceutically acceptable salts thereof, their amide derivatives, and compositions comprising at least 50% of these compounds.
Inventor(s):Napolitano Roberta, Lattuada Luciano, Baranyai Zsolt, Guidolin Nicole, Marazzi Giuseppe
Assignee:BRACCO IMAGING S.P.A.
Application Number:US16766619
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,973,934

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986-001 Sep 21, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986-002 Sep 21, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986-003 Sep 21, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,973,934

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019319599 ⤷  Sign Up
Brazil 112021001102 ⤷  Sign Up
Canada 3105610 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.